Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management

MLA

N Lynn, Henry, et al. “Aromatase Inhibitor-Associated Musculoskeletal Symptoms: Etiology and Strategies for Management.” Oncology (Williston Park, N.Y.), vol. 22, no. 12, Dec. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6c423b036015bcc15a954535453723cf&authtype=sso&custid=ns315887.

APA

N Lynn, H., Jon T, G., & Vered, S. (2008). Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park, N.Y.), 22(12).

Chicago

N Lynn, Henry, Giles Jon T, and Stearns Vered. 2008. “Aromatase Inhibitor-Associated Musculoskeletal Symptoms: Etiology and Strategies for Management.” Oncology (Williston Park, N.Y.) 22 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........6c423b036015bcc15a954535453723cf&authtype=sso&custid=ns315887.